AACR logo

Advertisement

Table of Contents

Cancer Immunity, an open access journal of the Cancer Research Institute Cancer Vaccines 2005: Barriers, Endpoints & Opportunities October 5-7, 2005 New York, USA Sponsored by the Cancer Research Institute

Session I: Innate Immunity

Session I: Innate Immunity

Genetic analysis of innate immunity

Bruce Beutler

Cancer Immun January 1 2006 6 (Suppl 1)
Session I: Innate Immunity

NK cell-mediated tumor immune surveillance

Mark J. Smyth, Nadeen Zerafa, Erika Cretney, Michele W. L. Teng, Jeremy Swann and Yoshihiro Hayakawa

Cancer Immun January 1 2006 6 (Suppl 1)
Session I: Innate Immunity

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

David H. Raulet

Cancer Immun January 1 2006 6 (Suppl 1)

Session II: Imaging the Immune Response to Infection and Cancer

Session II: Imaging the Immune Response to Infection and Cancer

Complex roles of the immunological synapse

Andrey S. Shaw

Cancer Immun January 1 2006 6 (Suppl 1)
Session II: Imaging the Immune Response to Infection and Cancer

In vivo visualization of CTL responses in lymph nodes

Ulrich H. von Andrian

Cancer Immun January 1 2006 6 (Suppl 1)
Session II: Imaging the Immune Response to Infection and Cancer

Dynamic in vivo high resolution imaging of immune cell behavior

Ronald N. Germain, Alex Y. Huang, Hai Qi, Marcello Chieppa, Maria Rescigno, Jackson Egen, Flora Castellino, Ina Ifrim, Clemens Scheinecker, Gregoire Altan-Bonnet, Anthony Rothfuchs, Alan Sher, Marc Bajénoff, Nicholas Glaichenhaus, Katrin Eichelberg, Ze Wang and Sabine Stoll

Cancer Immun January 1 2006 6 (Suppl 1)
Session II: Imaging the Immune Response to Infection and Cancer

Visualizing inflammatory chemokine-guided recruitment of naive CD8+ T cells to sites of antigen-dependent CD4+ T cell-dendritic cell interaction in situ

Alex Y. Huang, Flora Castellino, Grégoire Altan-Bonnet, Sabine Stoll, Clemens Scheinecker and Ronald N. Germain

Cancer Immun January 1 2006 6 (Suppl 1)
Session II: Imaging the Immune Response to Infection and Cancer

Leukemia and cancer stem cells

Irving L. Weissman

Cancer Immun January 1 2006 6 (Suppl 1)

Session III: Laboratory Monitoring of Human Anti-Tumor Responses

Session III: Laboratory Monitoring of Human Anti-Tumor Responses

In vivo antigen delivery by a Salmonella type III secretion system for therapeutic cancer vaccine development

Jorge E. Galán, Hiroyoshi Nishikawa, Gabriel Briones, Sacha Gnjatic, Gerd Ritter and Lloyd J. Old

Cancer Immun January 1 2006 6 (Suppl 1)
Session III: Laboratory Monitoring of Human Anti-Tumor Responses

CT antigens, gametogenic recapitulation and tumorigenesis

Andrew J. Simpson, O. L. Caballero, Achim Jungbluth, Yao-Tseng Chen and Lloyd J. Old

Cancer Immun January 1 2006 6 (Suppl 1)
Session III: Laboratory Monitoring of Human Anti-Tumor Responses

Immune monitoring of T-cell responses to full-length tumor antigens

Danila Valmori

Cancer Immun January 1 2006 6 (Suppl 1)
Session III: Laboratory Monitoring of Human Anti-Tumor Responses

Evolution of NY-ESO-1 cancer vaccines: Lessons learned

Kunle Odunsi

Cancer Immun January 1 2006 6 (Suppl 1)

Session IV: Immunotherapy

Session IV: Immunotherapy

Overcoming obstacles to the generation of T cells for tumor therapy

Philip Greenberg, William Ho, Matthias Wolfl, Ryan Teague, Junko Morimoto, Michelle Dossett, Juergen Kuball, Yang Yang, Carla Fowler and Joe Blattman

Cancer Immun January 1 2006 6 (Suppl 1)
Session IV: Immunotherapy

Human cancer immunotherapy: progress and problems

Steven A. Rosenberg

Cancer Immun January 1 2006 6 (Suppl 1)
Session IV: Immunotherapy

Balancing tumor immunity and autoimmunity

Glenn Dranoff

Cancer Immun January 1 2006 6 (Suppl 1)
Session IV: Immunotherapy

Checkpoint blockade in tumor immunotherapy

James P. Allison

Cancer Immun January 1 2006 6 (Suppl 1)
Session IV: Immunotherapy

Manipulation of co-signal pathways to enhance cancer vaccines

Lieping Chen

Cancer Immun January 1 2006 6 (Suppl 1)

Session V: Tregs and Other Checkpoints

Session V: Tregs and Other Checkpoints

Regulatory T cells in anti-tumor immune response

Hiroshi Shiku

Cancer Immun January 1 2006 6 (Suppl 1)
Session V: Tregs and Other Checkpoints

Regulatory CD4 T cells

Alexander Rudensky

Cancer Immun January 1 2006 6 (Suppl 1)
Session V: Tregs and Other Checkpoints

Regulatory T cells in ovarian cancer: biology and therapeutic potential

Tyler J. Curiel, Brian Barnett, Ilona Kryczek, Pui Cheng and Weiping Zou

Cancer Immun January 1 2006 6 (Suppl 1)
Session V: Tregs and Other Checkpoints

Functional control of regulatory T cells by TLR signaling

Rongfu Wang

Cancer Immun January 1 2006 6 (Suppl 1)

Session VI: DCs, CD8s, CD4s, Stem Cells

Session VI: DCs, CD8s, CD4s, Stem Cells

Dendritic cells mobilize NKT lymphocytes as adjuncts and adjuvants for anti-tumor immunity

Ralph M. Steinman

Cancer Immun January 1 2006 6 (Suppl 1)
Session VI: DCs, CD8s, CD4s, Stem Cells

T-help, TRAIL, and CTL memory

Stephen P. Schoenberger, Edith M. Janssen, Nathalie Droin, Edward Lemmens, Thomas Griffith and Douglas Green

Cancer Immun January 1 2006 6 (Suppl 1)

Closing Remarks

Closing Remarks

Cancer Vaccines 2005: Closing remarks

Kunle Odunsi

Cancer Immun January 1 2006 6 (Suppl 1)